Patent details
EP1282439 Title: PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A TFPI INHIBITOR
Basic Information
- Publication number:
- EP1282439
- PCT Application Number:
- PCT/DK/2001/000324
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP019314608
- PCT Publication Number:
- WO/2001/085199
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A TFPI INHIBITOR
- French Title of Invention:
- COMPOSITION PHARMACEUTIQUE COMPRENANT UN FACTEUR VIIa ET UN INHIBITEUR DE TFPI
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND EINEN FAKTOR VIIa UND EINEN TFPI-INHIBITOR
- SPC Number:
Dates
- Filing date:
- 10/05/2001
- Grant date:
- 30/11/2005
- EP Publication Date:
- 30/11/2005
- PCT Publication Date:
- 15/11/2001
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 12/02/2003
- EP B1 Publication Date:
- 30/11/2005
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 10/05/2006
- Expiration date:
- 10/05/2021
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/05/2001
- Name:
- Novo Nordisk Health Care AG
- Address:
- Andreasstrasse 15, 8050 Zürich, Switzerland (CH)
Inventor
- Name:
- KJALKE Marianne
- Address:
- Denmark (DK)
Priority
1
- Priority Number:
- 200000771
- Priority Date:
- 10/05/2000
- Priority Country:
- Denmark (DK)
2
- Priority Number:
- 200000778
- Priority Date:
- 10/05/2000
- Priority Country:
- Denmark (DK)
3
- Priority Number:
- 200000871
- Priority Date:
- 06/06/2000
- Priority Country:
- Denmark (DK)
Classification
- Main IPC Class:
- A61K 38/36;
| Filing date | Document type | Number of pages |
|---|